Vice President, Global Access
Margaret Keane leads Global Access at IAVI. This department develops and executes access plans to help enable broad and timely access to products through an understanding of the needs, preferences, and behaviors of populations most affected by HIV/AIDS. Keane engages with key external stakeholders, including industry partners, to optimize target product profiles and access approaches aimed at expediting the adoption of HIV vaccines and other biomedical HIV prevention products, TB vaccines and most recently, COVID-19 vaccines.
Before joining IAVI, Keane was at Merck for 30 years and was responsible for designing and implementing external collaboration models to facilitate product development and expand access to Merck vaccines and medicines. In addition, Keane served as an alliance manager to the MSD Wellcome Trust Hilleman Laboratories to develop new and optimized vaccines to meet the needs of developing countries. She was also an MSD Global Health fellow with Pathfinder International and World Health Partners in India.
Keane holds a B.A. from Wilmington College, an M.S. from Drexel University, and an MBA from Villanova University.